Evidence map›Paper›PMID 29997321›Full record

ArticleInternational journal of molecular sciences2018

Concentrated Conditioned Media from Adipose Tissue Derived Mesenchymal Stem Cells Mitigates Visual Deficits and Retinal Inflammation Following Mild Traumatic Brain Injury.

Kumar Abhiram Jha, Mickey Pentecost, Raji Lenin, Lada Klaic, Sally L Elshaer, Jordy Gentry, John M Russell, Alex Beland, Anton Reiner, Veronique Jotterand and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 2 syntheses or guidelines pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. TNF-Stimulated Gene-6, Part of Extracellular Vesicles in Adipose Tissue-Derived Mesenchymal Stem Cell Concentrated Conditioned Medium, Affects Microglial Activity.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Secretome as a Tool to Treat Neurological Conditions: Are We Ready?International journal of molecular sciences · 2023
    Review
  14. Review
  15. Review
  16. Tauroursodeoxycholic Acid Alleviates Endoplasmic Reticulum Stress-Mediated Visual Deficits in Diabetic tie2-TNF Transgenic Mice via TGR5 Signaling.Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2023
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Kumar Abhiram JhaDepartment of Ophthalmology, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA. kjha@uthsc.edu.
Mickey PentecostCell Care Therapeutics, Inc., Monrovia, CA 91016, USA. mickey.pentecost@gmail.com.
Raji LeninDepartment of Ophthalmology, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA. rrajeshl@uthsc.edu.
Lada KlaicCell Care Therapeutics, Inc., Monrovia, CA 91016, USA. lklaic@cell-care.com.
Sally L ElshaerDepartment of Ophthalmology, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA. slelshaer@gmail.com.
Jordy GentryDepartment of Ophthalmology, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA. jgentr21@uthsc.edu.
John M RussellDepartment of Ophthalmology, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA. jrusse74@uthsc.edu.
Alex BelandCell Care Therapeutics, Inc., Monrovia, CA 91016, USA. abeland16@students.kgi.edu.
Anton ReinerDepartment of Ophthalmology, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA. areiner@uthsc.edu.
Veronique JotterandCell Care Therapeutics, Inc., Monrovia, CA 91016, USA. vjotterand@cell-care.com.
Nicolas SohlCell Care Therapeutics, Inc., Monrovia, CA 91016, USA. nsohl@cell-care.com.
Rajashekhar GangarajuDepartment of Ophthalmology, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA. sgangara@uthsc.edu.ORCID 0000-0002-6664-8286
University of Tennessee Health Science Center · USCellerant Therapeutics (United States) · US

Funding

Vascular and Neuronal Repair with Adipose Stromal Cells in RetinopathyR01EY023427 · NEI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI GANGARAJU, RAJASHEKHAR · 2013 to 2017
$1.8M
NEI NIH HHS R01 EY023427
6 · The paper itself

Abstract

Blast concussions are a common injury sustained in military combat today. Inflammation due to microglial polarization can drive the development of visual defects following blast injuries. In this study, we assessed whether anti-inflammatory factors released by the mesenchymal stem cells derived from adipose tissue (adipose stem cells, ASC) can limit retinal tissue damage and improve visual function in a mouse model of visual deficits following mild traumatic brain injury. We show that intravitreal injection of 1 μL of ASC concentrated conditioned medium from cells pre-stimulated with inflammatory cytokines (ASC-CCM) mitigates loss of visual acuity and contrast sensitivity four weeks post blast injury. Moreover, blast mice showed increased retinal expression of genes associated with microglial activation and inflammation by molecular analyses, retinal glial fibrillary acidic protein (GFAP) immunoreactivity, and increased loss of ganglion cells. Interestingly, blast mice that received ASC-CCM improved in all parameters above. In vitro, ASC-CCM not only suppressed microglial activation but also protected against Tumor necrosis alpha (TNFα) induced endothelial permeability as measured by transendothelial electrical resistance. Biochemical and molecular analyses demonstrate TSG-6 is highly expressed in ASC-CCM from cells pre-stimulated with TNFα and IFNγ but not from unstimulated cells. Our findings suggest that ASC-CCM mitigates visual deficits of the blast injury through their anti-inflammatory properties on activated pro-inflammatory microglia and endothelial cells. A regenerative therapy for immediate delivery at the time of injury may provide a practical and cost-effective solution against the traumatic effects of blast injuries to the retina.

Indexed as

Adipose TissueAnimalsAnti-Inflammatory AgentsBlast InjuriesBrain ConcussionCells, CulturedCulture Media, ConditionedDisease Models, AnimalEndothelial CellsGene Expression RegulationGlial Fibrillary Acidic ProteinHumansIntravitreal InjectionsMaleMesenchymal Stem CellsMiceAnti-Inflammatory AgentsCulture Media, ConditionedGlial Fibrillary Acidic Proteinglial fibrillary astrocytic protein, mouseadult stem cellsmicrogliaoxidative stressretinal ganglion cellsTBITIMP1trans-endothelial electrical resistanceTSG6

Identifiers

PMID29997321
PMCPMC6073664
OpenAlexW2829450280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.